No abstract

Despite the absence of improvements in treatment options for melanoma, survival improved significantly, except for elderly males.

Standard therapy was applied less often in elderly patients with a subsequent independent negative impact on survival. Furthermore, high toxicity rate and the impossibility of the majority of patients to complete treatment were seen. This implies that better treatment strategies should be devised including a proper selection of senior patients for this aggressive chemotherapy.

ABSTRACTsive lymphoma and classified as DLBCL (since 84% of aggressive lymphoma is DLBCL) for the incidence analyses. This was done to minimize the effect of changes in classification on outcome of trends analyses of incidence. For the survival analyses, we excluded the unspecified cases.Year of diagnosis was divided into four periods for DLBCL and

Conditional 5-year relative survival for patients with HNSCC remains poorer compared to age- and sex-matched counterparts in the general population, even when alive at 15 years after diagnosis. We assume that this is caused by an excess comorbidity in these patients, mainly due to smoking and alcohol abuse.